Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid. 2007

Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
Department of Pharmaceutics and Department of Medicinal Chemistry and Natural Products, School of Pharmacy, Faculty of Medicine, and the David R. Bloom Centre for Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.

Valproic acid (VPA) is a major antiepileptic drug (AED); however, its use is limited by two life-threatening side effects: teratogenicity and hepatotoxicity. Several constitutional isomers of VPA and their amide and urea derivatives were synthesized and evaluated in three different anticonvulsant animal models and a mouse model for AED-induced teratogenicity. The urea derivatives of three VPA constitutional isomers propylisopropylacetylurea, diisopropylacetylurea, and 2-ethyl-3-methyl-pentanoylurea displayed a broad spectrum of anticonvulsant activity in rats with a clear superiority over their corresponding amides and acids. Enanatiomers of propylisopropylacetylurea and propylisopropylacetamide revealed enantioselective anticonvulsant activity, whereas only enantiomers of propylisopropylacetylurea displayed enantioselective teratogenicity. These potent urea derivatives caused neural tube defects, but only at doses markedly exceeding their effective dose, whereas VPA showed no separation between its anticonvulsant activity and teratogenicity. The broad spectrum of anticonvulsant activity of the urea derivatives coupled with their wide safety margin make them potential candidates to become new, potent AEDs.

UI MeSH Term Description Entries
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid
D017029 Epilepsy, Complex Partial A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic (cryptogenic partial complex epilepsy) or occur as a secondary manifestation of a focal cortical lesion (symptomatic partial complex epilepsy). (From Adams et al., Principles of Neurology, 6th ed, pp317-8) Complex Partial Epilepsy,Complex Partial Seizure Disorder,Cryptogenic Partial Complex Epilepsy,Disorder, Complex Partial Seizures,Epilepsy, Cryptogenic, Partial Complex,Epilepsy, Psychic Equivalent,Epilepsy, Psychomotor,Epilepsy, Symptomatic, Partial Complex,Partial Complex Epilepsy, Cryptogenic,Partial Complex Epilepsy, Symptomatic,Seizure Disorder, Complex Partial,Symptomatic Partial Complex Epilepsy,Partial Epilepsy, Complex,Psychic Equivalent Epilepsy,Psychomotor Epilepsy
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
May 2015, Epilepsy & behavior : E&B,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
January 2008, Neurotoxicology and teratology,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
July 2013, Naunyn-Schmiedeberg's archives of pharmacology,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
August 1997, Research communications in molecular pathology and pharmacology,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
January 1981, Archives internationales de pharmacodynamie et de therapie,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
March 1984, Neurology,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
January 1996, Archiv der Pharmazie,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
November 1978, Hospital practice,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
September 1978, Neurology,
Jakob Avi Shimshoni, and Meir Bialer, and Bogdan Wlodarczyk, and Richard H Finnell, and Boris Yagen
November 1978, JAMA,
Copied contents to your clipboard!